Prescient Therapeutics LimitedASX: PTX

PTX to resume Clinical Trial of PTX-200 in Ovarian Cancer

Nov 6, 2017 at 3:08 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment